Aralez Pharma Stock Price (OTCMKTS:ARLZQ)

Add to My Stocks
$0.02 $0 (0%) ARLZQ stock closing price Sep 18, 2018 (Closing)
Prev Close* : $0.02
Market Cap:
$1.55M
Day Low: $0.02
52 Week Low: $0.00
Open: $0.02
Volume: -
Day High: $0.03
52 Week High: $2.98
Dividend:
0.00

Latest Stock Market News

Latest Articles

Aralez Pharma News - From Partners

Aralez Announces Several Corporate Updates   by PRNews on Apr 20, 2016

ARLZQ Stockcharts

View ARLZQ PE ratio, PS ratio stocks charts and compare with peers.
ARLZQ Chart
Note: Compare Aralez Pharma stock price history with the index and industry peers.

Aralez Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
0.01
PB ratio (
price to book ratio
)
0.03

Aralez Pharma Returns

ROE
(return on equity)
-246%

Aralez Pharma Financial Ratios

Asset Turnover
0.33
Receivables Turnover
7.02
Debt to Equity
-
Dividend Yield
0%

ARLZQ Industry Peers

Company Price Change (%)
Skinvisible (SKVI)0.020 (0%)
Auris Medical (EARS)0.290 (0%)
Novadel Pharma (NVDL)0.010 (0%)
Ore Holdings (ORXE)0.190 (0%)
Anika Therapeutics (ANIK)40.980 (0%)
Ampio Pharma (AMPE)0.520.04 (7.14%)
Flexion Therapeutics (FLXN)19.80.07 (0.35%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 18, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 18, 2018

Aralez Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues105.94M54.27M21.39M32.39M10.32M
Net Income-125.2M-102.97M-37.78M19.67M-16.7M
Total Operating Expense188.93M145.07M58.85M15.8M27.1M
View Aralez Pharma income statement
balance sheet20172016201520142013
Total Assets453.47M517.37M32.25M50.45M35.33M
Total Liabilities438.25M397.89M17.47M3.71M17.54M
Shareholders Equity15.21M119.48M14.78M46.74M17.78M
View Aralez Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities12.86M-2.19M13.73M-18.53M11.76M
Net Cash from (used by) Operating Activities-28.78M-83.73M-16.78M--0.87M
Increase (Decrease) in Prop Plant And Equipment-1.29M-4.16M-0.24M-0.01M-
View Aralez Pharma cash flow statement

Aralez Pharma Stock Message Board

Related to Aralez Pharma Stock Quotes

Stocks from Medical-Drugs, Aralez Pharma stock chart